Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancer
Sara Moufarrij(George Washington University), Katherine B. Chiappinelli(George Washington University)
Cited by 112
Related Papers
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer
|Cell|2017|521
Inhibiting DNA methylation and RNA editing upregulates immunogenic RNA to transform the tumor microenvironment and prolong survival in ovarian cancer
|Journal for ImmunoTherapy of Cancer|2022|37
Oncogenic Transformation Drives DNA Methylation Loss and Transcriptional Activation at Transposable Element Loci
|Cancer Research|2023|27
Reduced DICER1 Elicits an Interferon Response in Endometrial Cancer Cells
|Molecular Cancer Research|2012|21